G protein-coupled receptors (GPCRs) represent the largest family of human membrane proteins. Four subtypes of adenosine receptors (ARs), the AAR, AAR, AAR and AAR, each with a unique pharmacological profile and distribution within the tissues in the human body, mediate many physiological functions and serve as critical drug targets for treating numerous human diseases including cancer, neuropathic pain, cardiac ischemia, stroke and diabetes. The AAR and AAR preferentially couple to the G proteins, while the AAR and AAR prefer coupling to the G proteins. Adenosine receptors were the first subclass of GPCRs that had experimental structures determined in complex with distinct G proteins. Here, we will review recent studies in molecular simulations and computer-aided drug discovery of the adenosine receptors and also highlight their future research opportunities.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000248 | PMC |
http://dx.doi.org/10.3390/molecules27072054 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!